Mckesson Medical-Surgical Inc. Corporate Office 2025-07-30 Health serious FDA
Health · FDA · Recall #FDA-D-0539-2025
EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx… Recall
Issued July 30, 2025 · Mckesson Medical-Surgical Inc. Corporate Office
In July 2025, Mckesson Medical-Surgical Inc. Corporate Office recalled the EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations; potential temperature excursions due to transit delays
What you should do
- 1 Stop using EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Mckesson Medical-Surgical Inc. Corporate Office to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Health
- Recall date
- July 30, 2025
- Units affected
- Not reported
- Sold at
- Within the U.S - OH, VA, FL.
- Recall number
- FDA-D-0539-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Mckesson Medical-Surgical Inc. Corporate Office has 76 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.